• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Streamline Health Solutions Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

    9/26/24 5:21:21 PM ET
    $STRM
    EDP Services
    Technology
    Get the next $STRM alert in real time by email
    strm20240919_8k.htm
    false 0001008586 0001008586 2024-09-25 2024-09-25
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     
     
     
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of The
    Securities Exchange Act of 1934
     
    Date of Report (Date of earliest event reported): September 25, 2024
    --01-31
     
    Streamline Health Solutions, Inc.
    (Exact name of registrant as specified in its charter)
     
    Delaware
     
    0-28132
     
    31-1455414
    (State or other jurisdiction of incorporation)
     
    (Commission File Number)
     
    (I.R.S. Employer Identification No.)
     
    2400 Old Milton Pkwy., Box 1353
    Alpharetta, GA 30009
    (Address of principal executive offices) (Zip Code)
    Registrant’s telephone number, including area code: (888) 997-8732
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Title of each class
     
    Trading Symbol
     
    Name of each exchange on which registered
    Common Stock, $0.01 par value
     
    STRM
     
    Nasdaq Capital Market
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
     
    Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
     
     

     
     
    Item 3.03.         Material Modification to Rights of Security Holders.
     
    To the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this Current Report on Form 8-K is incorporated herein by reference.
     
    Item 5.03.         Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. 
     
    As previously disclosed, at a special meeting of stockholders (the “Special Meeting”) of Streamline Solutions, Inc. (the “Company”) held on September 19, 2024, the Company’s stockholders approved a proposal authorizing the board of directors (the “Board”) to amend the Company’s Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to effect a reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding shares of common stock (the “Common Stock”) at a ratio of any whole number between 1-for-5 and 1-for-15, at any time prior to October 4, 2024, with the exact ratio to be set within that range at the discretion of the Board, without further approval or authorization of the Company’s stockholders.
     
    On September 20, 2024, the Board approved a reverse stock split ratio of one-for-fifteen (1:15). On September 25, 2024, the Company filed a Certificate of Amendment to the Certificate of Incorporation (the “Amendment”) with the Delaware Secretary of State to effect the Reverse Stock Split at ratio of one-for-fifteen (1:15), effective as of 12:01 a.m., Eastern Daylight Time, on October 4, 2024 (the “Effective Time”). The Common Stock will continue to be traded on The Nasdaq Capital Market under the symbol “STRM”. The Company expects the Common Stock will begin trading on a split-adjusted basis when the market opens on October 4, 2024, under CUSIP number 86323X205.
     
    At the Effective Time, each fifteen (15) shares of Common Stock issued and outstanding at such time shall, automatically and without any further action on the part of the Company or the holder thereof, be combined into one (1) validly issued, fully paid and non-assessable share of Common Stock, without effecting a change to the par value per share of Common Stock.
     
    No fractional shares shall be issued in connection with the Reverse Stock Split, and, in lieu thereof, the Company shall pay each stockholder of record at the time of effectiveness of the Reverse Stock Split who otherwise would be entitled to receive fractional shares because such stockholder holds a number of pre-Reverse Stock Split shares not evenly divisible by the number of pre-Reverse Stock Split shares for which each post-Reverse Stock Split share is to be exchanged an amount in cash equal to the fraction to which the stockholder would otherwise be entitled multiplied by the closing sales price of the Common Stock as reported on The Nasdaq Capital Market on the date on which the Effective Time occurs.
     
    The Reverse Stock Split shall also apply to any outstanding securities or rights convertible into, or exchangeable or exercisable for, Common Stock and all references to such Common Stock in agreements, arrangements, documents and plans relating thereto or any option or right to purchase or acquire shares of Common Stock shall be deemed to be references to the Common Stock or options or rights to purchase or acquire shares of Common Stock, as the case may be, after giving effect to the Reverse Stock Split. Additionally, all equity awards outstanding immediately prior to the Reverse Stock Split will be proportionately adjusted.
     
    The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by the full text of the Amendment, a copy of which is filed hereto as Exhibit 3.1 and is incorporated herein by reference.
     
    Item 7.01          Regulation FD Disclosure.
     
    On September 26, 2024, the Company issued a press release announcing the Reverse Stock Split and the filing of the Certificate of Amendment. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated by reference herein.
     
    Item 9.01         Financial Statements and Exhibits.
     
    (d) Exhibits.
     
     

     
     
    EXHIBIT
    NUMBER
     
    DESCRIPTION
         
    3.1*
     
    Certificate of Amendment to Certificate of Incorporation
    99.1
     
    Press Release dated September 26, 2024
    104
     
    Cover Page Interactive Data File (embedded within the Inline XBRL document)
     
    *Filed herewith. 
     
     

     
     
    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     
    STREAMLINE HEALTH SOLUTIONS, INC.
       
    Date: September 26, 2024
    By:
    /s/ Bryant J. Reeves, III
       
    Bryant J. Reeves, III
       
    Chief Financial Officer
     
     
     
    Get the next $STRM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STRM

    DatePrice TargetRatingAnalyst
    11/21/2022$3.00Buy
    Lake Street
    More analyst ratings

    $STRM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Streamline Health® Reports Fiscal First Quarter 2025 Financial Results

    ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced financial results for the fiscal first quarter of 2025 which ended April 30, 2025. Fiscal First Quarter Financial Results Total revenue for the first quarter of fiscal 2025 increased approximately 12% to $4.8 million as compared to $4.3 million during the first quarter of fiscal 2024. The change in total revenue was attributable to successful implementation of new SaaS contracts offset by client non-renewals. Saa

    6/16/25 4:05:04 PM ET
    $STRM
    EDP Services
    Technology

    MDaudit and Streamline Health Announce Definitive Merger Agreement

    The combined entity supports healthcare organizations nationwide with an aggregate Net Patient Revenue of more than $300B and brings together best-in-class billing compliance and revenue integrity solutions to empower health systems with actionable foresight and end-to-end visibility. MDaudit to acquire all outstanding shares of Streamline stock for $5.34 per share in cash, a premium of 138% to Streamline's closing price on May 28, 2025. Boston, Mass. and Atlanta, Ga., May 29, 2025 (GLOBE NEWSWIRE) -- MDaudit, an award-winning cloud-based continuous risk monitoring platform that enables the nation's premier healthcare organizations to minimize billing risks and maximize revenues, and St

    5/29/25 8:00:00 AM ET
    $STRM
    EDP Services
    Technology

    Streamline Health® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results

    ATLANTA, May 01, 2025 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced financial results for the fourth quarter and fiscal year 2024, which ended January 31, 2025. Management Commentary "As of January 31, 2025, our solutions are delivering an annualized financial impact of more than $210 million to our clients by helping them better control revenue cycle outcomes — and we're just getting started. We're focused on deepening that impact with targeted innovation in fiscal 2025. Our new d

    5/1/25 4:10:58 PM ET
    $STRM
    EDP Services
    Technology

    $STRM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lucas Kenan disposed of $1,806,415 worth of shares (338,280 units at $5.34) (SEC Form 4)

    4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)

    8/14/25 9:22:15 PM ET
    $STRM
    EDP Services
    Technology

    Chief People Officer Lovvorn Wendy L returned 27,216 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)

    8/14/25 1:14:58 PM ET
    $STRM
    EDP Services
    Technology

    SEC Form 4 filed by Streamline Health Solutions Inc.

    4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)

    8/14/25 1:12:19 PM ET
    $STRM
    EDP Services
    Technology

    $STRM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street resumed coverage on Streamline Health with a new price target

    Lake Street resumed coverage of Streamline Health with a rating of Buy and set a new price target of $3.00

    11/21/22 9:57:20 AM ET
    $STRM
    EDP Services
    Technology

    $STRM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Stilwill Benjamin Louis bought $1,008 worth of shares (6,300 units at $0.16), increasing direct ownership by 1% to 611,576 units (SEC Form 4)

    4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)

    9/24/24 4:58:31 PM ET
    $STRM
    EDP Services
    Technology

    $STRM
    SEC Filings

    View All

    SEC Form 15-12G filed by Streamline Health Solutions Inc.

    15-12G - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)

    8/22/25 12:12:26 PM ET
    $STRM
    EDP Services
    Technology

    SEC Form EFFECT filed by Streamline Health Solutions Inc.

    EFFECT - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)

    8/18/25 12:15:11 AM ET
    $STRM
    EDP Services
    Technology

    SEC Form EFFECT filed by Streamline Health Solutions Inc.

    EFFECT - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)

    8/18/25 12:15:10 AM ET
    $STRM
    EDP Services
    Technology

    $STRM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Streamline Health Solutions Inc.

    SC 13G - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)

    9/27/23 3:10:25 PM ET
    $STRM
    EDP Services
    Technology

    SEC Form SC 13D/A filed by Streamline Health Solutions Inc. (Amendment)

    SC 13D/A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)

    6/22/23 5:20:33 PM ET
    $STRM
    EDP Services
    Technology

    SEC Form SC 13G/A filed by Streamline Health Solutions Inc. (Amendment)

    SC 13G/A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)

    2/3/23 3:17:59 PM ET
    $STRM
    EDP Services
    Technology

    $STRM
    Financials

    Live finance-specific insights

    View All

    Streamline Health® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results

    ATLANTA, May 01, 2025 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced financial results for the fourth quarter and fiscal year 2024, which ended January 31, 2025. Management Commentary "As of January 31, 2025, our solutions are delivering an annualized financial impact of more than $210 million to our clients by helping them better control revenue cycle outcomes — and we're just getting started. We're focused on deepening that impact with targeted innovation in fiscal 2025. Our new d

    5/1/25 4:10:58 PM ET
    $STRM
    EDP Services
    Technology

    Streamline Health® Reports Fiscal Third Quarter 2024 Financial Results, Accelerates Anticipated Adjusted EBITDA Breakeven Timeline

    Net loss of ($2.5 million) during the third quarter of fiscal 2024 compared to a net loss of ($11.9 million) during the third quarter of fiscal 2023Company reiterated $15.5 million implemented SaaS ARR adjusted EBITDA breakeven run rate expectationCompany accelerated expectation for achievement of SaaS ARR adjusted EBITDA breakeven run rate to the first half of fiscal 2025 ATLANTA, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced financial results for the third quarter of

    12/16/24 4:33:39 PM ET
    $STRM
    EDP Services
    Technology

    Streamline Health® To Report Fiscal Third Quarter 2024 Financial Performance

    ATLANTA, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced that it will release its financial results for the three month period ended October 31, 2024 on Monday December 16, 2024 after the close of the financial markets. The Company will conduct a conference call on Tuesday, December 17, 2024, at 9:00 AM ET to review results and provide a corporate update. Interested parties can access the call by joining the live webcast: click here to register. You can also join by phon

    12/9/24 5:15:00 PM ET
    $STRM
    EDP Services
    Technology

    $STRM
    Leadership Updates

    Live Leadership Updates

    View All

    Streamline Health® Improves Liquidity Position and Appoints New Directors

    Streamline expects $4.5 million of additional liquidity will enable achievement of previously announced adjusted EBITDA breakeven of $15.5 million of installed SaaS ARR during the second half of fiscal 2024 Expanded board of directors with appointment of CEO Benjamin Stilwill and Matthew EtheridgeClosed private placement of unsecured subordinated notes and warrants and private placement of common stock resulting in aggregate gross proceeds of approximately $4.5 millionModified existing senior loan covenants Atlanta, GA, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM) ("Streamline" or "the Company"), a leading provider of solutions that enable healthc

    2/7/24 4:31:00 PM ET
    $STRM
    EDP Services
    Technology